Advanced Drainage Systems (WMS) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
14 Aug, 2026Executive summary
Net sales rose 21% year-over-year to $1,001 million, driven by strong growth in both Stormwater and Wastewater segments and the NDS acquisition, which contributed $94.7–$95 million in sales.
Adjusted EBITDA increased 28.8% to $358.3 million, with margin expanding by 230 basis points to 35.8%, among the highest in company history.
Net income from continuing operations rose 22.5% to $176.6 million; diluted EPS increased 22.8% to $2.26.
Growth was supported by diversified portfolio, disciplined price-cost management, material conversion, and operational execution.
Favorable pricing offset inflationary pressures, with peak material inflation expected in Q2.
Financial highlights
Stormwater sales increased 24% to $809–$809.4 million, including $94.7–$95 million from NDS; Wastewater sales rose 7.5–8% to $191.7 million.
Gross profit improved 23.5% to $408 million, with gross margin up to 40.8% from 39.8% year-over-year.
Free cash flow totaled $203–$203.2 million for the quarter, down from $222–$222.4 million year-over-year.
Adjusted EBITDA margin improved to 35.8% from 33.5% year-over-year.
Operating income rose to $254.5 million from $205.7 million; diluted EPS from continuing operations was $2.26, up from $1.84.
Outlook and guidance
Full-year net sales expected between $3.35 billion and $3.55 billion; adjusted EBITDA guidance of $1.0–$1.05 billion.
Capital expenditures for fiscal 2027 projected at approximately $200 million.
Adjusted EBITDA margin projected to be between 29.6% and 29.9%, down 170 to 200 basis points from FY26.
Management expects sufficient liquidity to meet working capital, capex, and debt obligations for at least the next twelve months.
Normal seasonality anticipated, with Q1 benefiting from revenue pulled forward due to price increases.
Latest events from Advanced Drainage Systems
- All proposals passed, including director elections and auditor ratification, with strong shareholder participation.WMS
AGM 2026 - Targeting >8% organic CAGR and >$1.2B EBITDA by FY30 through innovation and disciplined capital deployment.WMS
Investor Day 2026 - Strong financial results, performance-based executive pay, and enhanced ESG initiatives highlighted.WMS
Proxy filing - Votes will be held on directors, auditor ratification, and executive compensation.WMS
Proxy filing - Strong FY26 growth from acquisitions and product mix; FY27 outlook sees sales up but margins tighter.WMS
Q4 2026 - Flat Q2 sales, resilient margins, profit down; FY25 outlook reflects Orenco acquisition, cost pressures.WMS
Q2 2025 - Q1 sales up 4.8% to $815M; margin strong at 33.8%, but net income down 6.7%.WMS
Q1 2025 - FY25 net sales up 1% to $2.90B, with margin pressure and cautious FY26 outlook.WMS
Q4 2025 - Net sales up 4.3% in Q3 FY25, but net income and margins declined amid higher costs.WMS
Q3 2025